Concepedia

Amy C. DeBaillie

AC

Statistics

Publications

13

Citations

411

H-Index

11

Active since

2003

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (Spain)

University of North Carolina at Chapel Hill

Amy C. DeBaillie is an author at Eli Lilly (United States) specializing in medicinal chemistry, synthetic medicinal chemistry, and drug discovery.

Publications per year

2003–2020

13

Publications

13

Stereoselective Synthesis of γ-Substituted (<i>Z</i>)-Allylic Boranes via Kinetically Controlled Hydroboration of Allenes with 10-TMS-9-borabicyclo[3.3.2]decane

Jérémy Kister, Amy C. DeBaillie, Ricardo Lira et al. · Journal of the American Chemical Society · 2009 · 99 citations · Full text

, , +10

Enantioselective Total Synthesis of Bistramide A

Michael T. Crimmins, Amy C. DeBaillie · Journal of the American Chemical Society · 2006 · 96 citations · Full text

, , +9

Enantioselective Total Synthesis of (+)-Rogioloxepane A

Michael T. Crimmins, Amy C. DeBaillie · Organic Letters · 2003 · 46 citations

, , +13

Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus

Chafiq Hamdouchi, Pranab Maiti, Alan M. Warshawsky et al. · Journal of Medicinal Chemistry · 2017 · 30 citations · Full text

, , +17

Synthesis of BACE Inhibitor LY2886721. Part II. Isoxazolidines as Precursors to Chiral Aminothiazines, Selective Peptide Coupling, and a Controlled Reactive Crystallization

Marvin M. Hansen, Daniel J. Jarmer, Enver Arslantas et al. · Organic Process Research & Development · 2015 · 29 citations

, , +13

1–5 of 13